Our previous report also indicated that COL11A1 promotes tumor aggressiveness via the TGF-β1–MMP3 axis, and that a NF-YA-binding site on the COL11A1 promoter is the major determinant of TGF-β1-dependent COL11A1 activation21. Here, NFYA is linked to neoplasm.